Peptide Therapy

Short chain amino acids are the building blocks of proteins. They are involved in almost every function in the human body, from cell communication to metabolism

Semaglutide

Semaglutide, sold under the brand names Ozempic (FDA Approved 2017), Wegovy (FDA Approved 2021), & Rybelsus (FDA Approved 2019).

Losing weight can be an incredibly difficult endeavor which can impact your lifestyle. We all know there are no magic pills & nothing works better than time & effort. Bergen Total Health offers medications that are available that can assist with weight loss, fat loss, & even helps control insulin levels. The best part, these medications only have to be administered once a week.

Semaglutide, often referred to by the brand names Ozempic and Wegovy®, is a Glucagon-like peptide-1 (GLP-1) produced by the gut. It increases insulin production, a hormone that lowers the blood sugar level while inhibiting glucagon secretion, which is a hormone that raises blood sugar, reduces appetite and energy intake while delaying gastric emptying. It was first developed in 2012 by Novo Nordisk as a longer-acting option to Liraglutide. In 2017 this drug was approved as an anti-diabetic medication used to treat type 2 diabetes and obesity. In June 2021, it got approved for chronic weight management in obese individuals with a (BMI) ≥ 30 kg/m2) or overweight (initial BMI ≥ 27 kg/m2) with at least one weight-related comorbidity.

Benefits of Semaglutide Peptide Therapy over time:

  • Reduces food intake by lowering appetite
  • Slows food digestion in the stomach
  • Decrease in overall body weight
  • Decreased cardiovascular outcomes in subjects with type 2 diabetes
  • Lower HbA1c levels
  • Enhance the growth of β cells in the pancreas

Risks:

The most common side effects may include: nausea, diarrhea, vomiting, constipation, stomach pain, headache, fatigue, dizziness, bloating, gas, & heartburn.

Scroll to Top